Quantum-Si Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Quantum-Si Quarterly Cash Flow Statements Table
Quarterly
|
Annual
| Unit: USD | 2024-12-31 | 2024-09-30 |
|---|---|---|
| cash flows from operating activities: | ||
| net income | -33,121,000 | -25,313,000 |
| adjustments to reconcile net income to net cash from operating activities: | ||
| depreciation and amortization | 994,000 | 1,158,000 |
| allowance for credit losses | ||
| non-cash lease expense | 616,000 | 618,000 |
| unrealized (gain) loss on trading securities | ||
| realized loss on trading securities | ||
| accretion on marketable securities | ||
| loss on disposal of fixed assets | ||
| write-down of inventory | -5,620,000 | 824,000 |
| goodwill impairment | ||
| change in fair value of warrant liabilities | 4,638,000 | -121,000 |
| change in fair value of contingent consideration | ||
| change in fair value of stock consideration | ||
| stock-based compensation | 2,405,000 | 2,411,000 |
| other | -1,000 | 1,000 |
| changes in operating assets and liabilities: | ||
| accounts receivable | -435,000 | -424,000 |
| inventory | 5,967,000 | 123,000 |
| prepaid expenses and other current assets | 1,031,000 | -1,431,000 |
| operating lease right-of-use assets | ||
| other assets | ||
| accounts payable | 301,000 | 194,000 |
| accrued expenses and other current liabilities | 2,678,000 | 1,861,000 |
| other long-term liabilities | 2,532,000 | -869,000 |
| operating lease liabilities | -3,414,000 | 9,000 |
| net cash from operating activities | -22,881,000 | -23,153,000 |
| capex | -1,435,000 | -975,000 |
| free cash flows | -24,316,000 | -24,128,000 |
| cash flows from investing activities: | ||
| purchases of property and equipment | -1,435,000 | -975,000 |
| internally developed software - capitalized costs | 0 | 0 |
| purchases of marketable securities | -107,390,000 | -53,255,000 |
| sales of marketable securities | ||
| net cash from investing activities | -5,925,000 | 5,870,000 |
| cash flows from financing activities: | ||
| proceeds from exercise of stock options | 934,000 | 2,000 |
| proceeds from issuance of common stock from “at-the-market” offering, net of commissions and issuance costs | ||
| proceeds from vesting of restricted stock | ||
| deferred offering costs | 0 | |
| payment of contingent consideration - business acquisition | ||
| payment of deferred consideration - business acquisition | ||
| refund of issuance costs | ||
| net cash from financing activities | 35,794,000 | 2,000 |
| effect of exchange rate changes on cash and cash equivalents | -15,000 | -3,000 |
| net increase in cash and cash equivalents | 6,973,000 | -17,284,000 |
| cash and cash equivalents at beginning of period | 0 | 0 |
| cash and cash equivalents at end of period | 6,973,000 | -17,284,000 |
| realized (gain) loss on trading securities | ||
| amortization on marketable securities | -2,194,000 | |
| gain on disposal of fixed assets | ||
| sales and maturities of marketable securities | 60,100,000 | |
| refund of issuance costs from 2021 business combination | 0 | |
| supplemental disclosure of non-cash investing and financing activities: | ||
| property and equipment purchased but not paid | 217,000 | |
| deferred offering costs payable | 0 | |
| (gain) loss on marketable securities | ||
| (gain) loss on disposal of fixed assets | ||
| supplemental disclosure of cash flow information: | ||
| cash paid for income taxes | ||
| other assets - related party | ||
| business acquisition | ||
| net proceeds from equity infusion from the business combination | ||
| payment of notes payable | ||
| stock issuance costs for series e convertible preferred stock | ||
| principal payments under finance lease obligations | ||
| cash received from exchange of research and development tax credits | ||
| forgiveness of related party promissory notes | ||
| noncash equity issuance - business acquisition | ||
| noncash equity related warrants from the business combination | ||
| conversion of the convertible preferred stock into class a and class b common stock | ||
| noncash contingent consideration and holdbacks - business acquisition | ||
| loss on marketable securities | ||
| proceeds from issuance of series e convertible preferred stock | ||
| proceeds from issuance of notes payable | ||
| supplemental disclosure of noncash information: | ||
| noncash acquisition of property and equipment |
We provide you with 20 years of cash flow statements for Quantum-Si stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Quantum-Si stock. Explore the full financial landscape of Quantum-Si stock with our expertly curated income statements.
The information provided in this report about Quantum-Si stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.